Salem Erode Investments rights issue sees 102% subscription

scanx
Reviewed by
Shraddha JScanX News Team
Key Highlights
  • Salem Erode Investments Limited finalized its rights issue allotment with a subscription rate of 102.47%
  • The company raised up to ₹2,293.10 lakh through the issuance of 1,14,65,520 equity shares at ₹20 each
  • Valid applications totaled 302, with 231 initial applications rejected due to technical reasons
  • Trading of the newly allotted shares is scheduled to commence on or before October 8, 2026
powered bylight_fuzz_icon
52908041

*this image is generated using AI for illustrative purposes only.

Salem Erode Investments Limited has finalized the basis of allotment for its rights issue, which received valid applications amounting to 102.47% of the offered equity shares. The company raised up to ₹2,293.10 lakh by issuing fully paid-up equity shares at a price of ₹20 each.

The issue opened for subscription on September 15, 2026, and closed on October 1, 2026. Out of the total 533 applications received for 1,17,86,899 rights equity shares, 231 applications were rejected due to technical reasons. This left 302 valid applications for 1,17,48,413 rights equity shares, exceeding the total number of shares allotted under the issue.

Allotment details

The Board of Directors approved the allotment of rights equity shares to successful applicants on October 5, 2026. The allotment was finalized in consultation with the Registrar to the Issue and BSE, the designated stock exchange. No rights equity shares have been kept in abeyance.

Category Valid applications Rights shares applied Rights shares allotted
Eligible Equity Shareholders 223 56,17,455 56,17,455
Renouncees 79 61,30,958 58,48,065
Total 302 1,17,48,413 1,14,65,520

Subscription analysis

The subscription level indicates strong participation from both existing shareholders and renouncees. Eligible equity shareholders accounted for 73.84% of the valid applications, while renouncees contributed 26.16%. The total value of rights equity shares applied for stood at ₹23,49,68,260, compared to the allotted value of ₹22,93,10,400 (calculated as 1,14,65,520 shares at ₹20).

What the Numbers Show

The data reveals a slight divergence between application volume and final allotment. While 302 valid applications sought 1,17,48,413 shares, only 1,14,65,520 shares were allotted. This difference of 2,82,893 shares suggests that some additional bids from renouncees were partially rejected or scaled down during the allotment process, as the total applied shares exceeded the total offered shares by approximately 2.47%. The high number of technical rejections (231 out of 533) also highlights potential procedural hurdles for retail applicants using the ASBA mechanism.

Listing and trading timeline

The dispatch of allotment advice cum unlocking intimation to investors commenced and completed on October 6, 2026. Instructions to self-certified syndicate banks (SCSBs) for unblocking funds in ASBA applications were issued on October 5, 2026. The listing application was filed with stock exchanges on October 5, 2026, and BSE granted listing approval on October 6, 2026.

The credit of rights equity shares in dematerialized form to respective demat accounts of allottees was completed on October 6, 2026. Upon receipt of trading approvals, the rights equity shares are expected to commence trading on or before October 8, 2026, under the same ISIN as existing equity shares. Investors are advised that these shares can be traded only in dematerialized form.

Historical Stock Returns for Salem Erode Investments

1 Day5 Days1 Month6 Months1 Year5 Years
-7.66%-17.34%-20.79%-17.57%0.0%+366.97%

How will Salem Erode Investments deploy the ₹2,293.10 lakh raised from the rights issue to impact its future capital expenditure or debt reduction strategies?

What is the expected short-term price volatility for the stock upon its listing on October 8, given the 102.47% oversubscription and dilution effects?

Will the high rate of technical rejections (43% of applications) prompt the company or exchanges to implement stricter investor education or system upgrades for future ASBA-based issues?

Salem Erode Investments
View Company Insights
View All News
like18
dislike

Salem Erode Investments reappoints Balan as Independent Director

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Re-appointed Ambadath Aiyyappan Balan as Independent Director for a second five-year term
  • New term runs from September 29, 2026, to September 28, 2031
  • All three AGM resolutions passed with 100% votes in favor
  • Promoter group held 94.4% of total votes polled during e-voting
powered bylight_fuzz_icon
52409569

*this image is generated using AI for illustrative purposes only.

Salem Erode Investments Limited shareholders approved the re-appointment of Mr. Ambadath Aiyyappan Balan as an Independent Director for a second term of five years during the 95th Annual General Meeting (AGM). The meeting was held virtually on September 30, 2026.

The re-appointment resolution, passed via special resolution, received 100% support from the votes polled. Mr. Balan’s new term commences on September 29, 2026, and will conclude on September 28, 2031. The company submitted the consolidated voting results and scrutinizer's report to the BSE on October 1, 2026.

Director Profile and Governance Details

Mr. Ambadath Aiyyappan Balan (DIN: 01996253) is a Civil Engineering graduate from the Madras Government Technical Education Board, having completed his course in 1957 with specialization in Surveying and Levelling, Building Materials, and Construction. He is a Partner of Balan Construction Company and possesses over six decades of experience in the construction industry. He was conferred the Vikas Ratna Award by the International Friendship Society of India for his contributions to the building sector. The disclosure confirms he is not related to any other directors of the company.

Other Resolutions Passed

The meeting also adopted the audited financial statements for the financial year ended March 31, 2026, through an ordinary resolution. This resolution received 100% support from the votes polled, with no votes cast against it.

Ms. Umadevi Anilkumar was re-appointed as a director in place of herself, who retired by rotation. This ordinary resolution passed with requisite majority, supported by all valid votes cast.

Voting Participation Details

The e-voting facility remained open from September 27, 2026, to September 29, 2026. A total of 39 members participated in the remote e-voting process across all three resolutions. The promoter group held a significant stake, casting 85,99,140 votes in favor of each resolution. Public non-institutional shareholders contributed 5,05,104 votes, while public institutions did not cast any votes.

Resolution Type Votes Polled In Favor Against Result
Adoption of Financial Statements Ordinary 91,04,244 91,04,244 0 Passed
Re-appointment of Umadevi Anilkumar Ordinary 91,04,244 91,04,244 0 Passed
Re-appointment of A.A. Balan (ID) Special 91,04,244 91,04,244 0 Passed

What the Numbers Show

The data reveals a high concentration of voting power among the promoter group. Promoters accounted for approximately 94.4% of the total votes polled (85,99,140 out of 91,04,244). Consequently, the unanimous passage of all resolutions, including the critical re-appointment of the Independent Director, was mathematically guaranteed by the promoter's holding alone, rendering the dissenting potential of minority shareholders negligible in this instance.

Historical Stock Returns for Salem Erode Investments

1 Day5 Days1 Month6 Months1 Year5 Years
-7.66%-17.34%-20.79%-17.57%0.0%+366.97%

How will the continued dominance of promoter voting power (94.4%) impact the company's future governance scores and institutional investor confidence?

Given Mr. Balan's age and 60+ years of industry experience, what succession planning or board refreshment strategies is Salem Erode Investments likely to implement before his term ends in 2031?

Will the lack of institutional shareholder participation in the AGM signal a broader disinterest that could affect liquidity and valuation multiples for the stock?

Salem Erode Investments
View Company Insights
View All News
like20
dislike

More News on Salem Erode Investments

1 Year Returns:0.00%